Page last updated: 2024-11-03

promethazine and Endocardial Fibroelastosis

promethazine has been researched along with Endocardial Fibroelastosis in 1 studies

Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.

Endocardial Fibroelastosis: A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krovetz, LJ1
McLoughlin, TG1
Schiebler, GL1

Other Studies

1 other study available for promethazine and Endocardial Fibroelastosis

ArticleYear
Left ventricular function in children studied by increasing peripheral resistance with angiotensin.
    Circulation, 1968, Volume: 37, Issue:5

    Topics: Adolescent; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiomegaly; Child; Child, Pre

1968